← All patents

US20230190812A1

Engineered t cell receptors and methods of use

University of Texas System

Abstract

This disclosure provides for engineered T cell Receptors (TCRs), cells comprising the TCRs, and methods of making and using the TCRs. The current disclosure relates to TCRs that specifically recognize cancer testis (CT) antigens of the MAGE-A4 antigen. Accordingly, aspects of the disclosure relate …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Cassian Yee
Priority date
May 18, 2020
Filing date
May 17, 2021
Publication date
June 22, 2023
Language
en
Metadata fetched
August 29, 2026 00:30